anti-0c3H antiserum a 50% lysis titer of 1:64, both as measured by a sLCr release assay with LN target cells and simultaneous EB-FDA viability test. After liver absorption (31) specificity controls were done using a titer of 1:10 of either anti-0 serum and testing BM, thymus, or LN. It was found that both sera lysed 1% BM, 99% thymus, and 65-70% LN when tested in an EB-FDA viability test. Functionally, these sera (plus complement) destroyed CLP cells, but lost this activity when absorbed with thymus.
Guinea pig serum Clow-tox," Cedarlane Laboratories) was used as a source of complement. This was absorbed with mouse spleen cells syngeneic to the cell suspension to be treated, filtered through a 0.2-/~m Millex filter (Millipore Corp., Bedford, Mass.) and stored at -20°C until use. For anti-0 serum treatment cells were incubated with anti-0 serum (final dilution of 1:10) in 6% BSAphosphate-buffered saline (PBS) at a concentration of 107 cells/ml for 30 min at 4°C. The cells were then washed once with 10 ml of 5% BSA-PBS, resuspended in either 5% BSA-PBS (no complement control) or in a 1:6 dilution of guinea pig serum, incubated at 37°C for 45 min in an atmosphere of humidified 10% CO2 in air, washed once in 2-ME free standard medium and once in standard medium, and resuspended to the desired concentration in standard medium.
Alloantisera. For one experiment an anti-H-2 ~ alloantiserum was needed. This was made according to the injection schedule of Gregory et al. (32) with the modification that B6C3F~ spleen cells were injected (instead of B6 cells) into C3H/HeJ animals. The resulting ascites containing anti-H-2 b antibodies was absorbed twice with RNC-nu/+ spleen cells. The 50% lysis point using the treatment protocol, as described for the anti-0 serum treatment, was found to be 1:8 with (B6 × RNC)F~ nu/+ LN cells. Controls with RNC-nu/+ LN cells showed that there was no toxic effect against H-2 ~" cells at a 1:2 final titer, whereas 98% of F~ cells were killed under these conditions.
In Vitro Immunization.
Responder cells (usually 3 x 105-2 × 106 viable cells) were mixed with 2 × 10 ~ nucleated irradiated (1,500 reds) stimulator cells in 75-ram plastic tubes (no. 2058 Falcon Plastics, Oxnard, Calif.) containing 3 ml standard medium. In all experiments the strains for responder and stimulator cells were chosen as to avoid "backstimulation" (3, 33) . Thus the stimulator cells were always a hybrid strain (e.g., B6D2F~), whereas the respender cells were one of the parents (e.g., B6 when the target cell was H-2 d). Cultures were set up in duplicate and incubated for 4 days upright (loosely capped) at 37°C in a humidified atmosphere of 10% CO2 in air.
Micro-SLCr Release Test. A slightly modified micro version (34) of the original 5~Cr release was used. This micromodification avoids any centrifugation and allows one to assay for the cytootoxic activity of individual cultures. Briefly, it was performed as follows: The supernate from each culture to be assayed was removed using a specially designed pipette such that the pellet was reproducibly (coefficient of variation of 0.026) left in 0.28 ml medium. The pellet was then suspended, 0.1 ml transferred into the first well of a microtitor tray (Linbro IS-FB-96-TC), and another 0.1 ml transferred into the second well containing 0.1 ml assay medium to give the first dilution. After mixing, 0.1 ml of this well was carried over to the next well for the second dilution, etc. A separate dilution series was made for each culture. Preliminary experiments showed that it was not necessary to wash the cultured cells before the measurement of cytotoxicity. Next 0.1 ml (5 × 104 cells) of the labeled target cell suspension (see above) was added to each well and the trays incubated for 4 h at 37°C in a humidified atmosphere of 10% CO2 in air. Then, 0.1 ml of supernate was collected from each well using a 100 ~l Eppendorf pipette placed into a special stand to insure that the distance between the pipette and the bottom of the microtiter well was constant, thus avoiding accidental sucking up of target cells. Control cultures with only responder cells or only stimulator cells were added at a fourfold dilution to 5 x 104 target cells to estimate the background 5~Cr release, which varied from 6-12% of the total 5~Cr incorporated. The total releasable 5~Cr was estimated by diluting 0.1 ml of the target cells into 1.5 ml of counting fluid (1% acetic acid in distilled water) which usually gave 75-80% release. Counts were performed in an LKB Wallac 80,000 automatic gamma sample counter. Under the labeling conditions described above, 5 × 104 cells gave 8,000-11,000 cpm.
Quantitation of the relative frequency of cytotoxic effector cells was done as described elsewhere (7) . Briefly, this is as follows: Specific 5~Cr release, p, in each microtiter well was calculated as (observed counts -background)/(total releasable -background). It can be shown (7) that the fraction of target cells lysed is given by f = 1 -e-~, where N is the total number of sensitized cells, a is proportional to the frequency of CTL, and t is the assay time. Under appropriate conditions (t ~ 1.5 h, sensitized lymphocyte to target cell ratio not too high), f = p, so that Na (1 -p ) . All of the data below (except for Fig. 1 ) are presented in terms of N a rather than t p. By comparing Fig. 1 with Fig. 2 or 3 one can see that each titration curve of the type shown in Fig. 1 is represented by a single Na value, directly proportional to the number of CL in that culture.
Statistical Analysis.
Using the above analysis, each titration curve in the micro-5'Cr release test could be reduced to give one Na value using the best fit to the data points. We observed empirically that titration curves of replicate cultures with small Na values showed a greater dispersion than replicate cultures with high Na values. To quantitate this observation we analyzed 53 titration curves, each of which had been done in triplicate or quadruplicate. For each set of replicates, the arithmetic mean Na and the dispersion (coefficient of variation [CV]) was calculated. A negative linear relationship between the logarithms of the Na values and the coefficient of variation was found: log,o (CV) = -0.361 log,o (Na) -0.925. The correlation coefficient for this regression line was 0.95. We could therefore use this relationship to estimate the CV for the mean Na of replicate cultures. Error bars shown throughout are 95% confidence limits calculated from this formula. In the remainder of this paper, only Na values will be presented. Each has been derived from titration curves similar to those shown in Fig. 1 . For convenience, they are always given multiplied by 104. A numerical value for "cytotoxic activity/ culture" refers to this parameter.
Results

Synergism Between Small Numbers of nu/+ LN Cells and nu/nu
Spleen. Fig. 1 shows ~'Cr cytotoxicity titration curves for three different cultures. In each culture either 2 x 105 B6-nu/+ LN cells, or l0 s B6-nu/nu spleen cells, or both together were cultured along with 2 × 106 irradiated (1,500 rads) B6D2F1 spleen cells. On day 4, various dilutions of each culture, as shown in the figure, were titrated for their ability to lyse cells bearing D2 alloantigens using 51Cr-labeled P815 cells. It is clear from the figure that the nu/nu spleen cells, although inactive when cultured separately, appear to synergize with nu/+ LN cells to give a much larger cytotoxic response than that of nu/+ LN cells cultured alone.
Several possible procedures exist for quantitating the activity of each culture and thus assessing more directly the degree of synergism. We have chosen to do this by calculating from each titration curve the relative number of cytotoxic lymphocytes present in the culture according to the procedure outlined in Materials and Methods and described in detail elsewhere (7) . This analysis yields a numerical value for a parameter Na which is proportional to the total number of cytotoxic lymphocytes in the culture. For the nu/+ LN curve, Na = 0.012 and for the nu/+ LN + nu/nu spleen curve, Na = 0.056, or 4.7 times as active. To distinguish between these two possibilities, an approach based on genetic differences in the population cultured was taken. If nu/nu spleen cells have a specific role in the induction of cytotoxic effector cells under the conditions described above, then the synergism should be influenced by the genetic relationship between the nu/nu spleen cells and the stimulator cells. Varying numbers of nu/nu spleen cells from B6 (H-2b), RNC (H-2k), and the F1 hybrid between them were tested for their capacity to synergize with constant small numbers of B6 nu/+ LN cells. All cultures also contained irradiated C3B6F1 one experiment are shown in Fig. 7 . Here, day 4 cultures were treated with specific anti-H-2 b alloantisera immediately before doing the 51Cr release test. This alloantiserum should destroy cytotoxic activity derived from (RNC × B6) FI cells, but not RNC cells. It was observed (Fig. 7) that the cytotoxic activity was destroyed only when the LN cells were of F1 origin. Thus, all the cytotoxic activity is derived from the nu/+ LN cells, and no detectable activity comes from the nu/nu spleen cells.
To confirm that in a synergizing culture all the effector cells are T cells, we treated the effector cells with anti-Thy-1.2 (AKR anti-0c3H) serum before the ~lCr release test. The results (Fig. 8, groups 1-3) show that all the cytotoxic effector cells are Thy-l.2 positive. In the same experiment nu/nu spleen cells were added to nu/+ -nu/nu spleen cultures on day 4 just before the 5~Cr release test to determine whether the nu/nu spleen cells must be present for all of the 4-day culture period to obtain synergism. It can be seen (groups 4 and 5, Fig. 8 ) that late addition of nu/nu spleen cells produced no change in the cytotoxic activity over that measured for nu/+ LN cells alone. To find out whether the interacting cell types in the induction phase of cytotoxic lymphocyte production from mixtures of nu/+ LN and nu/nu spleen cells were each of T-cell origin, we treated each component separately with RAMB serum before mixing with the other cell component. The cell mixtures were then cultured for 4 days and assayed for cytotoxic activity. As shown in Fig. 9 , four different absorption controls were included to test the specificity of the antiserum. Clearly, the cell provided by the nu/+ LN is a T cell, since the cytotoxic activity of the antiserum is absorbed both by thymus and nu/+ spleen, but not by nu/nu spleen or nu/+ bone marrow. In contrast, when the same batch of absorbed sera was used with nu/nu spleen cells, a different pattern was found (Fig. 9) . The unabsorbed serum produced a slight reduction in activity. This does not, however, appear to be due to an anti-Thy-l.2 activity in the serum as nu/nu spleen absorbed this cytotoxic activity as effectively as nu/+ thymus. Similar results were found using a mouse AKR anti-ec3H serum with the same absorption controls (data not shown). It is concluded, therefore, that the active cell type in nu/+ LN is Thy-l.2 positive, and the active cell in nu/nu spleen is Thy-l.2 negative. Discussion We have demonstrated that there is a synergism between non-T and T cells in the in vitro generation of CTL under optimized culture conditions which include 2-ME. We interpret our data as indicating that non-T cells play an obligatory role in the generation of CTL from their progenitors (CLP), which are T cells (35) . This interaction leads to the activation of CLP and the antigen-specific production of CTL. It is stressed that the interaction between non-T cells and T cells is possible across major histocompatibility differences including/-region differences. It is also important to note that the nu/+ LN may, in fact, provide two unique T cells, one of which is the CLP and the other of which amplifies the response of the CLP (36) .
Group nul+ nulnu Treatment
Cytotoxic activity No.
LN spleen be foreS~CR per culture (xlO "6) (x10 -6 ) release test 0 i000 2000 3000 4000 , and that addition of nu/nu spleen cells to the cultures just before the cytotoxicity assay has no effect on the measured cytotoxicity (groups 4-5). All cultures also contained 2 x 106 irradiated (1,500 rads) C3D2F, spleen cells as stimulator cells and were assayed using P815 mastocytoma cells as target cells.
Exclusion of Simple Explanations for Synergism. It has been shown by
Pierce et al. (18) that macrophages have two functions in an in vitro immune response to Sheep red blood cells (SRBC), a viability promotion function and an antigen presentation function. The viability promotion function can be duplicated by 2-ME as shown by various authors (14-19). Broome and Jeng (16) also showed that 2-ME-like conditioned medium can promote the growth of L1210 cells which otherwise would not grow in Eagle's basal medium. We controlled for these growth-promoting effects by optimizing the FCS concentration and by including 2-ME. Preliminary experiments showed that 10% FCS, 5 × 10 -5 M 2-ME, and 3 ml total culture volume were optimal for 4-day cultures as described in this paper. In addition, the genetic studies showed that addition of allogeneic some cultures in a manner inconsistent with the sole effect being that of viability promotion (Figs. 4-6 ). Viability tests of these 4-day cultures revealed that all of the groups had a viability of 30-40%, although both their relative cytotoxicity and total cell yield showed big differences in the same experiment (Figs. 4-6 ). We conclude, therefore, that under the culture conditions described above, cultures are saturated for the viability promotion function of macrophages and any additional activity must be due to some other mechanism. One other such mechanism could be a mitogenic effect (37). It is conceivable that allogeneically stimulated nude spleen cells or nu/+ LN cells produce a mitogen that "amplifies" the CLP activation. However, this does not seem to be the case. Compare, for example, groups 1, 2, and 3 of Fig. 6 : cytotoxic activity of groups 2 (both nu/+ and nu/nu receiving H-2-difference stimulation) is the same as group 3 (only nu/+ receiving H-2-difference stimulation) and much less than group 1.
Another mechanism of activation, namely backstimulation (3, 33), can be excluded as accounting for the synergism, since all nu/+ LN -nu/nu spleen cell mixtures have been expressly chosen to avoid this phenomenon. In some cases, this required using P815 cells as stimulator cells (38) instead of spleen cells (e.g., groups 9-12, Fig. 6 ). The allogeneic responder cell mixtures used (e.g., groups 2, 6, and 10, Fig. 6 ) are unlikely to be affected by backstimulation, because RNC nu/nu spleen cells lack T cells (24) which would be required to recognize the B6 nu/+ LN cells (3, 24) . In these cultures, stimulator-responder backstimulation is controlled by taking F~ stimulator cells. In Fig. 6 , the only groups in which backstimulation might be a problem are groups 14 and 15. These only served as controls in the comparison of groups 9-12 and 13-16 to demonstrate that P815 cells are equivalent to spleen cells in their function as stimulator cells.
We conclude that the cause of the synergism is not of a trivial nature (viability promotion, mitogenic effect, backstimulation), but due to obligatory cell interactions between the nu/+ LN and nu/nu spleen cells.
Origin and Properties of Cytotoxic Effector Cells. Since it is established that nu/nu spleen cells cannot produce cytotoxic effector cells in MLC cultures (12, 24, and (42), "armed" macrophages (43, 44) , or antibody-dependent lysis (45) . All of these possibilities are excluded by the results of Fig. 7 , where parent-F1 cell mixtures were treated with alloantiserum and complement immediately before the micro-51Cr release test. If one of the above mechanisms were active, one should have seen some decrease of the activity when the cell mixture with F~ nu/nu spleen was treated. However, no change was seen (Fig. 7) . On the other hand, all of the activity was destroyed when the cell mixture containing F~ nu/+ LN cells was treated (Fig.  7) . This demonstrates that all the effector cells are derived from the LN cells, but does not bear on the question of what the nature of the effector cells is. In previous publications (13, 46) it was shown that CTL from normal MLR cultures are Thy-1 positive and that they lyse target cells specifically. To test whether or not the effector cells of synergistic cell mixtures are T cells, we treated cell mixtures of LN cells after 4 days of culture with anti-Thy-1 and complement immediately before the micro-51Cr release test. As shown in Fig. 8 (groups 1, 2 , and 3) all of the activity was destroyed, indicating that all the cytotoxic activity was due to T cells. In Fig. 6 (compare groups 1, 4 , 5, and 8) it is shown that this cytotoxic activity is specifically directed only against target cells carrying the same antigens against which the effector cells have been sensitized. We conclude from this that the effector cells produced appear to be identical with respect to two tested properties (Thy-1 antigen, specific lysis) to CTL developed in normal MLC cultures.
Properties of Active Cells in nu/nu Spleen. As shown in Fig. 9 , treatment with nu/nu spleen-absorbed RAMB serum before culture destroyed all the nu/+ LN cell activity but none of the nu/nu spleen cell activity. Similar results were obtained with liver-absorbed AKR anti-0c.~H serum indicating to us that the active subpopulation(s) in nu/nu spleen are not T cells.
Does the active cell type of nu/nu spleen have specific antigen recognizing function? This question was tested in Fig. 6 . As indicated above, syngeneic responder cell mixtures showed that antigen recognition and target cell lysis were antigen specific (groups 1, 4, 5, and 8 in Fig. 6 ). Two special cases with semiallogeneic and allogeneic responder cell mixtures were of interest to us because we saw no synergistic response. In the allogeneic responder cell mixture (groups 2 and 6), RNC nu/nu spleen cells recognize H-2 b antigens of the F~ stimulator cells, but B6 nu/+ LN cells recognize H-2 k antigens. We consider that this explains why there is no synergism against either KHT (H-2 k) or EL-4 (H-2 ~) target cells. In the other special case with semisyngeneic responder cell mixtures (groups 3 and 7, Fig. 6 ) there is no antigeneic stimulation of the F~ nu/ nu spleen cells since they are syngeneic to the stimulator cells, perhaps explaining why there is no synergism in this combination. In contrast, however, the same responder cell mixtures, when stimulated by a third party antigen which both components of the mixture can recognize, showed marked synergism (groups 10 and 11, Fig. 6 ).
In conclusion, these data are consistent with the hypothesis that the active cell type of nu/nu spleen has specific antigen-recognizing function. Collaboration between the nu/nu spleen cells and the nu/+ CLP requires that both recognize the same antigen. Collaboration is possible across an allogeneic difference including/-region differences, but only against a third party antigen.
This finding distinguishes our results from those of Rosenthal et al. (11, 22, 23) who found that, in responding to soluble protein antigens, the cooperation between macrophages and T lymphocytes of guinea pigs required identity at the major histocompatibility locus. The difference may be related to different requirements for responses to H-2 antigens and soluble protein antigens.
As shown in Fig. 2 , synergism occurs only at limiting numbers of nu/+ LN cells in the slope 2 region of a log-log plot. The observation that addition of nu/ nu spleen cells changes slope 2 of a log-log plot into slope 1 (Fig. 2) suggests that the cell type being diluted out in nu/+ LN is the same as the non-T cell in nu/nu spleen accounting for the synergism (47) .
Studies of the active cell in nu/nu spleen using velocity sedimentation cell separation, coupled with measurements of radiosensitivity and adherence properties indicate" that the major activity is due to a relatively radiation sensitive, nonadherent cell population with modal sedimentation velocity of 4.2 mm/h. In addition, there is a minor subpopulation of relatively radioresistant active cells with modal sedimentation velocity of about 6 mm/h. The observed sedimentation profiles are inconsistent with the active cells being B cells (48) , but have similarities to the profiles measured for A cells (49, 50) . Similar active cells can be seen in the spleen, LN, and peritoneal cells of normal mice (work in progress).
Summary
The ability of small numbers of LN cells to produce cytotoxic lymphocytes on in vitro culture with allogeneic stimulator cells is greatly augmented by the addition of spleen cells from athymic nude mice. The possibility that the synergism is a result of improved culture conditions or a "feeder effect" is . 2 Miller, R. G., R. M. Schilling, and R. A. Phillips. Manuscript in preparation.
excluded. All cytotoxic cells found in these cultures are shown to be T cells and to arise from precursors contained in the LN-cell component. The nude spleen cell component appears to be providing a required non-T cell which has been lost from the LN component through dilution. Synergism between the two components can occur whether they are syngeneic or allogeneic provided that both can recognize the same alloantigens in the stimulator population.
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